Development of human anti-murine antibody (HAMA) response in patients.
about
A novel antibody humanization method based on epitopes scanning and molecular dynamics simulationBotulinum neurotoxins and botulism: a novel therapeutic approach.Human antibodies from transgenic mice.An efficient method for variable region assembly in the construction of scFv phage display libraries using independent strand amplification.Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Rapid isolation of antibody from a synthetic human antibody library by repeated fluorescence-activated cell sorting (FACS)Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidatesInhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.Antibody Engineering for Pursuing a Healthier FutureEvaluation of EBV transformation of human memory B-cells isolated by FACS and MACS techniques.Toward a New Kind of Vaccine: A Logical Extension of the Symmetrical Immune Network TheoryGeneration and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).The evolution of fibrin-specific targeting strategies.Camelid Single-Domain Antibodies (VHHs) against Crotoxin: A Basis for Developing Modular Building Blocks for the Enhancement of Treatment or Diagnosis of Crotalic Envenoming.Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.Antibody Phage Display
P2860
Q31144470-BE51174A-BDC8-4E08-91C1-FDD94169C262Q34070659-5DF0DEA4-1B3C-467C-B1AB-B938B641D5E4Q34289925-1008113A-89FF-4555-9677-BF4D7B825E32Q34301659-64066253-4980-48E9-8995-158DDF9E7065Q34449304-DD13EF18-2172-4B35-8D44-704B2D6376AFQ35320978-C0544833-B572-4035-A728-A1B9CC916338Q35578028-6F5D3426-02C6-42E8-BFF5-85DAEDC44C97Q35926878-C75D9BA3-B9B6-4317-9217-4A88D7B8D818Q36317151-E2664F8C-C823-4C2A-99B4-CDBEA1A82CF9Q36710927-6E292E2B-12C5-4D01-AB46-F82F0864099FQ38206206-F08B11A8-705F-48A6-8D96-10333FBDEAD1Q38731632-3A57A36C-6508-4BA4-8929-C89C894CF214Q40819129-BDCD4A01-1959-4DC9-A960-E69FD44F4DAFQ41064032-F0E5FE2B-F601-47A0-8F4C-70659B427848Q42801724-F484454E-6B2C-47CC-83F5-8636F018EC4AQ44468366-B61B49AE-6532-444B-9F35-8EBB10AB8420Q47405444-77ABB0A1-0133-4FE6-844B-00887884ECF6Q49265874-A996E8E7-E711-42D6-BC90-E419C636D82BQ55179438-3F9A8353-7B86-420E-88B8-C7FFDCE35B9CQ55554478-A6F840AA-525B-4316-B0EF-F7D46893DDE5Q58007992-56DD8C71-663F-4992-AC4E-726B3359BC0C
P2860
Development of human anti-murine antibody (HAMA) response in patients.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Development of human anti-murine antibody (HAMA) response in patients.
@en
Development of human anti-murine antibody
@nl
type
label
Development of human anti-murine antibody (HAMA) response in patients.
@en
Development of human anti-murine antibody
@nl
prefLabel
Development of human anti-murine antibody (HAMA) response in patients.
@en
Development of human anti-murine antibody
@nl
P2093
P2860
P356
P1476
Development of human anti-murine antibody (HAMA) response in patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/ICB.1990.50
P478
68 ( Pt 6)
P577
1990-12-01T00:00:00Z
P6179
1038414353